학술논문

Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study
Document Type
Article
Source
In The Journal of Allergy and Clinical Immunology: In Practice April 2024 12(4):991-997
Subject
Language
ISSN
2213-2198